ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

NEXI NexImmune Inc

3.32
0.20 (6.41%)
04 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
NexImmune Inc NEXI NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.20 6.41% 3.32 08:57:13
Open Price Low Price High Price Close Price Previous Close
3.13 3.10 3.4899 3.32 3.12
more quote information »

Recent News

Date Time Source Heading
08/3/202405:20BWKonzernergebnis zum 31. Dezember 2023 genehmigt, starke..
08/3/202404:33BWApprobation des résultats financiers du groupe au 31..
07/3/202417:31BWApprovati i risultati finanziari di Gruppo al 31 dicembre..
07/3/202417:30BWGroup Financial Results as of December 31st 2023 Approved,..
07/2/202408:42GLOBENexImmune Announces Closing of $3.67 Million Registered..
07/2/202408:30EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
06/2/202409:10EDGAR2Form 8-K - Current report
06/2/202408:34EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
03/2/202406:00GLOBENexImmune Announces $3.67 Million Registered Direct Offering..
03/2/202405:25EDGAR2Form 8-K - Current report
02/2/202401:17EDGAR2Form 8-K - Current report
20/1/202408:43EDGAR2Form 8-K - Current report
19/1/202408:43EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
23/12/202308:01EDGAR2Form 8-K - Current report
02/12/202305:39EDGAR2Form 8-K - Current report
23/11/202309:40EDGAR2Form 144/A - Report of proposed sale of securities: [Amend]
23/11/202309:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/11/202308:39EDGAR2Form 144 - Report of proposed sale of securities
21/11/202309:19EDGAR2Form DEF 14A - Other definitive proxy statements
21/11/202309:01EDGAR2Form 8-K/A - Current report: [Amend]
18/11/202308:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
16/11/202308:17EDGAR2Form NT 10-Q - Notification of inability to timely file Form..
10/11/202309:47EDGAR2Form PRE 14A - Other preliminary proxy statements
10/11/202301:35BWFinanzergebnisse der Gruppe zum 30. September 2023..
10/11/202300:52BWLes résultats financiers du groupe au 30 septembre 2023 ont..
09/11/202317:30BWApprovati I Risultati Finanziari Di Gruppo Al 30 Settembre..
03/11/202308:12EDGAR2Form 8-K - Current report
03/11/202307:33EDGAR2Form 8-K - Current report
24/10/202323:00GLOBENexImmune, Yale, and JDRF Extend Research Partnership for..
19/10/202323:00GLOBENexImmune Announces Presentations at The Society for..
19/10/202307:15EDGAR2Form 8-K - Current report
19/10/202302:30GLOBENexImmune Announces 1-for-25 Reverse Stock Split
26/9/202306:42EDGAR2Form DEF 14A - Other definitive proxy statements
16/9/202306:06EDGAR2Form 8-K - Current report
14/9/202307:14EDGAR2Form PRE 14A - Other preliminary proxy statements
09/9/202309:23EDGAR2Form 3 - Initial statement of beneficial ownership of..
01/9/202307:11EDGAR2Form 8-K - Current report
01/9/202306:45GLOBENexImmune Announces Workforce Reduction to Enable Continued..
11/8/202306:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/8/202306:06EDGAR2Form 8-K - Current report
11/8/202306:01GLOBENexImmune Reports Second Quarter 2023 Financial Results and..
02/8/202308:21BWFinanzergebnisse der Gruppe zum 30. Juni 2023 bestätigen..
01/8/202315:23BWGroup Financial Results as of June 30th 2023, Approved Solid..
08/7/202306:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/7/202306:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/7/202306:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/7/202306:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/6/202322:01GLOBENexImmune Presents Initial Positive Data from the NEXI-001..
23/5/202306:01GLOBENexImmune Announces Poster Presentation at the 2023 FOCIS..
16/5/202306:01GLOBENexImmune Reports First Quarter 2023 Financial Results and..

Your Recent History

Delayed Upgrade Clock